Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call
13 Giugno 2024 - 2:00PM
Business Wire
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for cancer, announced today that it has updated the ASCO data
highlights conference call to Friday, June 21, 2024 at 8:00 a.m.
Pacific Time / 11:00 a.m. Eastern Time. Personalis had previously
announced it would host the conference call on Wednesday, June 19,
2024 at 1:00 p.m. Pacific Time / 4:00 p.m. Eastern Time.
Webcast and Conference Call Information
Interested parties may access the call by dialing 877-407-9042
for domestic callers or 201-689-8569 for international callers. The
webinar of the call may be accessed by visiting the Events section
of the company's website at investors.personalis.com. A replay of
the webinar will be available shortly after the conclusion of the
call and will be archived on the company's website.
About Personalis, Inc.
At Personalis, we are transforming the active management of
cancer through breakthrough personalized testing. We aim to drive a
new paradigm for cancer management, guiding care from biopsy
through the life of the patient. Our highly sensitive assays
combine tumor-and-normal profiling with proprietary algorithms to
deliver advanced insights even as cancer evolves over time. Our
products are designed to detect minimal residual disease (MRD) and
recurrence at the earliest time points, enable the selection of
targeted therapies based on ultra-comprehensive genomic profiling,
and enhance biomarker strategy for drug development. Personalis is
based in Fremont, California. To learn more, visit
www.personalis.com and connect with us on LinkedIn and X
(Twitter).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240613405471/en/
Investors: Caroline Corner investors@personalis.com
415-202-5678
Media: pr@personalis.com
Grafico Azioni Personalis (NASDAQ:PSNL)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Personalis (NASDAQ:PSNL)
Storico
Da Dic 2023 a Dic 2024